Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Larimar Therapeutics

Tracked across 2 events · 12 articles · First seen Jun 26, 2026 · Last active Jul 05, 2026

Sentiment
-25
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
3 20
Business
Impact: Larimar Therapeutics is hosting an investor event to provide updates on its Nomlab of USP clinical development program, including regulatory updates and data from an ongoing long-term study for Friedreich s ataxia. This event is crucial for the company to communicate its progress and future plans to investors.
Jun 26, 2026 · 6 articles
4 -70
Regulatory
Impact: Larimar Therapeutics is under investigation by Pomerantz LLP for alleged securities fraud and unlawful business practices related to its drug nomlabofusp, which has shown safety concerns in clinical trials, leading to significant stock price drops.
Jul 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Larimar Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.